LUYE pharma Joins US Firm to Develop Immuno-oncology Treatments

LUYE PHARMA announced that the Group entered into a collaboration and license agreement with Elpis Biopharm, a Boston-re...

May 29, 2018 | Tuesday | News
FDA approves BioMarin’s metabolic disorder treatment

Singapore- U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare...

May 25, 2018 | Friday | News
Eisai, Merck provide Update on sNDA for Lenvatinib

Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Dr...

May 25, 2018 | Friday | News
Celgene, Evotec team up on cancer treatments

Singapore- Celgene and German biotech Evotec AG have inked a long-term strategic drug discovery and development par...

May 22, 2018 | Tuesday | News
AstraZeneca submits sNDA for Forxiga in Japan

Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals...

May 22, 2018 | Tuesday | News
Minerva’s drug shows treatment effect in schizophrenia patients

 Singapore- Minerva Neurosciences, a clinical-stage biopharmaceutical company focused on the development of therapi...

May 18, 2018 | Friday | News
Cabometyx gets approval in Europe for first-line kidney cancer

 Singapore- The European Commission (EC) has approved commercialization partner Ipsen's marketing application for C...

May 18, 2018 | Friday | News
Regeneron, Sanofi's drug shows positive effect in lung cancer study

 Singapore- Regeneron Pharmaceuticals and development partner Sanofi announce positive preliminary data from a...

May 18, 2018 | Friday | News
Dicerna’s hyperoxaluria treatment gets orphan status from FDA

 Singapore- Dicerna Pharmaceutical’s drug recently received an orphan drug status designation for i...

May 18, 2018 | Friday | News
FDA approves first non-opioid treatment for opioid withdrawal

Singapore- The U.S. Food and Drug Administration approved privately held US WorldMeds LLC's Lucemyra (lofexidine hydroch...

May 17, 2018 | Thursday | News
Daré to merge with Pear Tree Pharma

Singapore– Daré Bioscience, a clinical-stage women’s biopharmaceutical company has agreed t...

May 8, 2018 | Tuesday | News
Kindred Biosciences Receives FDA Approval of Mirataz

Kindred Biosciences, Inc. a biopharmaceutical company focused on saving and improving the lives of pets, announced that ...

May 7, 2018 | Monday | News
Zai Lab in-licenses Entasis’s broad-spectrum antibiotic in APAC

Singapore – Shanghai-based Zai Lab Limited inks an exclusive license agreement with privately held Entasis Therape...

April 26, 2018 | Thursday | News
Pfizer vaccine receives FDA's breakthrough therapy designation

Pfizer recently announced that its lead Meningococcal Group B Vaccine TRUMENBA received Breakthrough Therapy designation...

April 25, 2018 | Wednesday | News
Zymeworks, Celgene expand bispecific antibody partnership

Singapore - Zymeworks, a clinical-stage biopharmaceutical company developing multifunctional therapeutics, announced tha...

April 24, 2018 | Tuesday | News
UCB to acquire Proximagen’s midazolam nasal spray

Singapore- Belgium based UCB announced an agreement to acquire the rights to Proximagen's Midazolam Nasal Spray (US...

April 20, 2018 | Friday | News
J&J ramps up pricing for Imbruvica

Singapore- Johnson & Johnson will implement a new pricing and dosage scheme for cancer med IMBRUVICA (ibrutinib) con...

April 19, 2018 | Thursday | News
OBI Pharma gets FDA clearance for new drug application

OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has cleared an i...

April 19, 2018 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls